Victor Musiime

Summary

Country: UK

Publications

  1. doi request reprint Anthropometric measurements and lipid profiles to detect early lipodystrophy in antiretroviral therapy experienced HIV-infected children in the CHAPAS-3 trial
    Victor Musiime
    Joint Clinical Research Centre, Kampala, Uganda
    Antivir Ther 19:269-76. 2014
  2. doi request reprint Bacteremia, causative agents and antimicrobial susceptibility among HIV-1-infected children on antiretroviral therapy in Uganda and Zimbabwe
    Victor Musiime
    Joint Clinical Research Center, Kampala, Uganda
    Pediatr Infect Dis J 32:856-62. 2013
  3. doi request reprint Antiretroviral drug resistance profiles and response to second-line therapy among HIV type 1-infected Ugandan children
    Victor Musiime
    Joint Clinical Research Centre JCRC, Kampala, Uganda
    AIDS Res Hum Retroviruses 29:449-55. 2013
  4. doi request reprint Response to antiretroviral therapy of HIV type 1-infected children in urban and rural settings of Uganda
    Victor Musiime
    Joint Clinical Research Centre, Headquarters, Kampala, Uganda
    AIDS Res Hum Retroviruses 28:1647-57. 2012
  5. doi request reprint Response to nonnucleoside reverse transcriptase inhibitor-based therapy in HIV-infected children with perinatal exposure to single-dose nevirapine
    Victor Musiime
    Joint Clinical Research Centre, Butikiro House, Kampala, Uganda
    AIDS Res Hum Retroviruses 25:989-96. 2009
  6. doi request reprint Enteric bacterial pathogens in HIV-infected children with acute diarrhea in Mulago referral and teaching hospital, Kampala, Uganda
    Victor Musiime
    Joint Clinical Research Centre, Clinic, Kampala, Uganda
    J Int Assoc Physicians AIDS Care (Chic) 8:185-90. 2009
  7. pmc Cardiac Dysfunction Among Ugandan HIV-infected Children on Antiretroviral Therapy
    Judith Namuyonga
    From the Department of Paediatrics, Makerere University College of Health Sciences Pediatric Cardiology Department, Uganda Heart Institute, Mulago Hospital Directorate of Research and Grants, Joint Clinical Research Centre JCRC and Clinic Department, Makerere University John Hopkins University MUJHU Care Limited, Kampala, Uganda
    Pediatr Infect Dis J 35:e85-8. 2016
  8. doi request reprint Acceptability of lopinavir/r pellets (minitabs), tablets and syrups in HIV-infected children
    Adeodata Kekitiinwa
    Department of Pediatrics and Adolescent Health, Baylor College of Medicine Children s Foundation Uganda, Paediatric Infectious Diseases Clinic, Mulago Hospital Kampala, Kampala, Uganda
    Antivir Ther 21:579-585. 2016
  9. pmc Single-dose nevirapine exposure does not affect response to antiretroviral therapy in HIV-infected African children aged below 3 years
    Philippa Musoke
    aBaylor Uganda, Paediatric Infectious Diseases Clinic, Mulago Hospital bMakerere University College of Health Sciences, Kampala, Uganda cMRC Clinical Trials Unit at University College London, London, UK dJoint Clinical Research Centre, Kampala, Uganda eUniversity of Zimbabwe College of Health Sciences, Harare, Zimbabwe fMedical Research Council Uganda Virus Research Institute Uganda Research Unit on AIDS, Entebbe, Uganda gZvitambo Institute for Maternal and Child Health Research, Harare, Zimbabwe hQueen Mary University of London, London, UK Philippa Musoke, Alexander J Szubert, A Sarah Walker and Diana M Gibb contributed equally to the writing of this article
    AIDS 29:1623-32. 2015
  10. doi request reprint Virologic Response to First-Line Efavirenz- or Nevirapine-Based Anti-Retroviral Therapy in HIV-Infected African Children
    Adeodata Kekitiinwa
    1Baylor Uganda, Paediatric Infectious Diseases Clinic, Mulago Hospital, Kampala, Uganda 2MRC Clinical Trials Unit at University College London, London, UK 3Medical Research Council Uganda Virus Research Institute Uganda Research Unit on AIDS, Entebbe, Uganda 4Joint Clinical Research Centre, Kampala, Uganda 5Makerere University College of Health Sciences, Kampala, Uganda 6University of Zimbabwe College of Health Sciences, Harare, Zimbabwe
    Pediatr Infect Dis J . 2016

Collaborators

  • Diana M Gibb
  • A Sarah Walker
  • Sabrina Bakeera-Kitaka
  • Marc Lallemant
  • Robert Colebunders
  • Peter N Mugyenyi
  • Job C J Calis
  • Grace A McComsey
  • Ying Jiang
  • Sarah A Walker
  • Paula Munderi
  • Adeodata Kekitiinwa
  • Alexander J Szubert
  • Cissy Kityo
  • Grace Mirembe
  • Judith Namuyonga
  • Andrew J Prendergast
  • Kusum Nathoo
  • Mutsawashe Bwakura-Dangarembizi
  • Sahera Dirajlal-Fargo
  • Irene Lubega
  • Peter Lwabi
  • Brigette Gleason
  • Sulaiman Lubega
  • Margaret J Thomason
  • Moira Spyer
  • Patricia Nahirya-Ntege
  • Philippa Musoke
  • Eva Natukunda
  • Adrian Cook
  • Julia Kenny
  • Nigel Klein
  • Sara Debanne
  • Robert A Salata
  • Tawanda Mhute
  • Emmy Okello
  • Richard Katuramu
  • Chris T Longenecker
  • Immaculate Nankya
  • Llilian Nakatudde-Katumba
  • Andrew Mukuye
  • David Baptiste
  • Tobias F Rinke de Wit
  • Ali Judd
  • Sarah Nakalanzi
  • Oscar Senfuma
  • Mary Kiconco
  • Elizabeth Kaudha
  • Kim Catherina Eve Sigaloff
  • Tamara Sonia Boender
  • Joshua Kayiwa
  • Kuda Mutasa
  • Zvenyika A Gomo
  • David Eram Williams
  • Patricia Nahirya
  • Cuthbert Musarurwa
  • Hilda Kizito
  • Francis Ssali

Detail Information

Publications18

  1. doi request reprint Anthropometric measurements and lipid profiles to detect early lipodystrophy in antiretroviral therapy experienced HIV-infected children in the CHAPAS-3 trial
    Victor Musiime
    Joint Clinical Research Centre, Kampala, Uganda
    Antivir Ther 19:269-76. 2014
    ..We compared body circumferences, skin-fold thickness (SFT) and lipids in antiretroviral therapy (ART)-naive and stavudine (d4T)-exposed children with HIV-uninfected controls...
  2. doi request reprint Bacteremia, causative agents and antimicrobial susceptibility among HIV-1-infected children on antiretroviral therapy in Uganda and Zimbabwe
    Victor Musiime
    Joint Clinical Research Center, Kampala, Uganda
    Pediatr Infect Dis J 32:856-62. 2013
    ..Bacteremia is common in HIV-infected children in Africa, including after start of antiretroviral therapy (ART), but there are limited data on causative pathogens and their antimicrobial sensitivity patterns in this population...
  3. doi request reprint Antiretroviral drug resistance profiles and response to second-line therapy among HIV type 1-infected Ugandan children
    Victor Musiime
    Joint Clinical Research Centre JCRC, Kampala, Uganda
    AIDS Res Hum Retroviruses 29:449-55. 2013
    ..Multiple RAMs were observed among HIV-1-infected children with virological failure on first-line ART with M184V and K103N most frequent. The children responded favorably to boosted PI-based second-line ART...
  4. doi request reprint Response to antiretroviral therapy of HIV type 1-infected children in urban and rural settings of Uganda
    Victor Musiime
    Joint Clinical Research Centre, Headquarters, Kampala, Uganda
    AIDS Res Hum Retroviruses 28:1647-57. 2012
    ..130), and in 78.8% of urban versus 88.8% of rural children by PC (p<0.0001). In this study rural children had more favorable clinical outcomes and were more likely to adhere optimally to ART than urban children...
  5. doi request reprint Response to nonnucleoside reverse transcriptase inhibitor-based therapy in HIV-infected children with perinatal exposure to single-dose nevirapine
    Victor Musiime
    Joint Clinical Research Centre, Butikiro House, Kampala, Uganda
    AIDS Res Hum Retroviruses 25:989-96. 2009
    ....
  6. doi request reprint Enteric bacterial pathogens in HIV-infected children with acute diarrhea in Mulago referral and teaching hospital, Kampala, Uganda
    Victor Musiime
    Joint Clinical Research Centre, Clinic, Kampala, Uganda
    J Int Assoc Physicians AIDS Care (Chic) 8:185-90. 2009
    ..HIV-infected children develop severe bacterial infections. We set out to determine the enteric bacterial pathogens in HIV-infected children and HIV-negative controls with acute diarrhea and their antimicrobial sensitivities...
  7. pmc Cardiac Dysfunction Among Ugandan HIV-infected Children on Antiretroviral Therapy
    Judith Namuyonga
    From the Department of Paediatrics, Makerere University College of Health Sciences Pediatric Cardiology Department, Uganda Heart Institute, Mulago Hospital Directorate of Research and Grants, Joint Clinical Research Centre JCRC and Clinic Department, Makerere University John Hopkins University MUJHU Care Limited, Kampala, Uganda
    Pediatr Infect Dis J 35:e85-8. 2016
    ..We sought to determine the prevalence, types and factors associated with cardiac abnormalities among HIV-infected Ugandan children on combination ART...
  8. doi request reprint Acceptability of lopinavir/r pellets (minitabs), tablets and syrups in HIV-infected children
    Adeodata Kekitiinwa
    Department of Pediatrics and Adolescent Health, Baylor College of Medicine Children s Foundation Uganda, Paediatric Infectious Diseases Clinic, Mulago Hospital Kampala, Kampala, Uganda
    Antivir Ther 21:579-585. 2016
    ..Lopinavir/ritonavir 'pellets' were recently tentatively approved for licensing. We describe their acceptability for infants and children up to 48 weeks...
  9. pmc Single-dose nevirapine exposure does not affect response to antiretroviral therapy in HIV-infected African children aged below 3 years
    Philippa Musoke
    aBaylor Uganda, Paediatric Infectious Diseases Clinic, Mulago Hospital bMakerere University College of Health Sciences, Kampala, Uganda cMRC Clinical Trials Unit at University College London, London, UK dJoint Clinical Research Centre, Kampala, Uganda eUniversity of Zimbabwe College of Health Sciences, Harare, Zimbabwe fMedical Research Council Uganda Virus Research Institute Uganda Research Unit on AIDS, Entebbe, Uganda gZvitambo Institute for Maternal and Child Health Research, Harare, Zimbabwe hQueen Mary University of London, London, UK Philippa Musoke, Alexander J Szubert, A Sarah Walker and Diana M Gibb contributed equally to the writing of this article
    AIDS 29:1623-32. 2015
    ..To assess the impact of exposure to single-dose nevirapine (sdNVP) on virological response in young Ugandan/Zimbabwean children (<3 years) initiating antiretroviral therapy (ART), and to investigate other predictors of response...
  10. doi request reprint Virologic Response to First-Line Efavirenz- or Nevirapine-Based Anti-Retroviral Therapy in HIV-Infected African Children
    Adeodata Kekitiinwa
    1Baylor Uganda, Paediatric Infectious Diseases Clinic, Mulago Hospital, Kampala, Uganda 2MRC Clinical Trials Unit at University College London, London, UK 3Medical Research Council Uganda Virus Research Institute Uganda Research Unit on AIDS, Entebbe, Uganda 4Joint Clinical Research Centre, Kampala, Uganda 5Makerere University College of Health Sciences, Kampala, Uganda 6University of Zimbabwe College of Health Sciences, Harare, Zimbabwe
    Pediatr Infect Dis J . 2016
    ..Poorer virologic response to nevirapine vs efavirenz-based antiretroviral therapy (ART) has been reported in adult systematic reviews and pediatric studies...
  11. pmc HIV Drug Resistance Among Children Initiating First-Line Antiretroviral Treatment in Uganda
    Cissy Kityo
    1 Joint Clinical Research Centre JCRC, Kampala, Uganda
    AIDS Res Hum Retroviruses 32:628-35. 2016
    ..This study aimed to assess the prevalence of primary HIVDR and associated risk factors among children initiating first-line antiretroviral therapy (ART) in Uganda...
  12. pmc Prevalence of lipodystrophy and metabolic abnormalities in HIV-infected African children after 3 years on first-line antiretroviral therapy
    Mutsawashe Bwakura-Dangarembizi
    University of Zimbabwe, College of Health Sciences, Harare, Zimbabwe Joint Clinical Research Centre Makerere University, College of Health Sciences, Kampala, Uganda Medical Research Council Clinical Trials Unit Centre for Paediatrics, Blizard Institute, Queen Mary University of London, London, United Kingdom Medical Research Council Uganda Virus Research Institute Uganda Research Unit on AIDS, Entebbe, Uganda and Pediatric Infectious Diseases Clinic Baylor Uganda, Mulago Hospital, Kampala, Uganda
    Pediatr Infect Dis J 34:e23-31. 2015
    ..Most pediatric lipodystrophy data come from high-income/middle-income countries, but most HIV-infected children live in sub-Saharan Africa, where lipodystrophy studies have predominantly investigated stavudine-based regimens...
  13. doi request reprint The pharmacokinetics and acceptability of lopinavir/ritonavir minitab sprinkles, tablets, and syrups in african HIV-infected children
    Victor Musiime
    Joint Clinical Research Centre, Kampala, Uganda Department of Pharmacy, Radboud University Medical Centre, Nijmegen, the Netherlands Baylor College of Medicine Children s Foundation Uganda, Mulago Hospital Kampala, Kampala, Uganda MRC Clinical Trials Unit at University College London, London, United Kingdom and Drugs for Neglected Diseases Initiative, Geneva, Switzerland
    J Acquir Immune Defic Syndr 66:148-54. 2014
    ..Guidelines recommend lopinavir/ritonavir (LPV/r) as first- and second-line therapy for young and older HIV-infected children, respectively. Available formulations have limitations making their widespread use complex...
  14. doi request reprint A Case of Cryptococcal Lymphadenitis in an HIV-Infected Child
    Eva Natukunda
    Joint Clinical Research Centre, Kampala, Uganda
    AIDS Res Hum Retroviruses 27:373-6. 2011
    ..Therefore cryptococcal lymphadenitis should be considered in the differential diagnosis of children presenting with lymphadenopathy and a positive serum CRAG...
  15. pmc Brief Report: Prevalence of Latent Rheumatic Heart Disease Among HIV-Infected Children in Kampala, Uganda
    Brigette Gleason
    Case Western Reserve University School of Medicine, Cleveland, OH University Hospitals Case Medical Center, Cleveland, OH Joint Clinical Research Center, Kampala, Uganda Makerere University School of Medicine, Kampala, Uganda and Uganda Heart Institute, Kampala, Uganda
    J Acquir Immune Defic Syndr 71:196-9. 2016
    ..82% (95% confidence interval: 0.26% to 2.23%), which is lower than the published prevalence rates of 1.5%-4% among Ugandan children. There may be protective factors that decrease the risk of RHD in HIV-infected children. ..
  16. doi request reprint Insulin Resistance and Markers of Inflammation in HIV-Infected Ugandan Children in the CHAPAS 3 Trial
    Sahera Dirajlal-Fargo
    1Case Western Reserve University, Cleveland, OH, 2Rainbow Babies and Children s Hospital, Cleveland, OH, 3Joint Clinical Research Centre, Kampala, Uganda, 4Makerere University College of Health Sciences, Kampala, Uganda, 5MRC Clinical Trials Unit University College, London, UK, 6Institute of Child Health University College, London UK
    Pediatr Infect Dis J . 2017
    ..Few studies have investigated metabolic complications in HIV-infected African children and their relation with inflammation...
  17. pmc Pubertal development in HIV-infected African children on first-line antiretroviral therapy
    Alexander J Szubert
    aMRC Clinical Trials Unit at University College London, London, UK bJoint Clinical Research Centre cMakerere University College of Health Sciences, Kampala, Uganda dUniversity of Zimbabwe, Harare, Zimbabwe eMedical Research Council Uganda Virus Research Institute Uganda Research Unit on AIDS, Entebbe fPaediatric Infectious Diseases Clinic Baylor Uganda, Mulago Hospital, Kampala, Uganda gQueen Mary University of London, London, UK All the authors contributed equally to the writing of this article
    AIDS 29:609-18. 2015
    ..To estimate age at attaining Tanner stages in Ugandan/Zimbabwean HIV-infected children initiating antiretroviral therapy (ART) in older childhood and investigate predictors of delayed puberty, particularly age at ART initiation...
  18. doi request reprint Pharmacokinetics and acceptability of once- versus twice-daily lamivudine and abacavir in HIV type-1-infected Ugandan children in the ARROW Trial
    Victor Musiime
    Joint Clinical Research Centre, Kampala, Uganda
    Antivir Ther 15:1115-24. 2010
    ..We compared the pharmacokinetics (PK) of once- versus twice-daily lamivudine and abacavir treatment using the World Health Organization recommended weight band dosing of scored adult tablets...